allodynia and semaglutide If your skin hurts to touch while on GLP-1, you're not imagining it. A new case series documents as a dose-dependent side effect of GLP-1 medications. Here's what we know so Participate in Allodynia Research for
Description
The FDA ended the semaglutide shortage in February 2025, which closed 503B mass-compounding of semaglutide copies
The date is typically printed on a label or directly on the glass

The participants were divided into two groups: insulin and exenatide
Are there state-specific limitations or different terms

These claims can sound appealing, especially when branded drugs are expensive or unavailable

In another study, it was shown to help people lose an average of 9.2% of their body weight after 56 weeks